Location: Boston, MA
CIK: 0001816307 · Show all filings
Period: Q3 2023 (← Previous) (Next →)
Filing Date: Nov 13, 2023
Total Value: $330M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| XBI | SPRD S&P Biotech ETF | 300,000 | $21.91M | 6.6% | — | — | Call | 78464A870 |
| — | ImmunoGen Inc | 1,307,435 | $20.75M | 6.3% | $17.62 | — | EQUITIES | 45253H101 |
| — | Morphic Holding Inc | 590,829 | $13.54M | 4.1% | $34.85 | — | EQUITIES | 61775R105 |
| — | Merus NV | 500,000 | $11.79M | 3.6% | $19.70 | — | EQUITIES | N5749R100 |
| SLNO | Soleno Therapeutics Inc | 370,000 | $10.92M | 3.3% | $6.05 | 0.0% | EQUITIES | 834203309 |
| — | Intra-Cellular Therapies Inc | 208,730 | $10.87M | 3.3% | $54.25 | — | EQUITIES | 46116X101 |
| — | Akero Therapeutics Inc | 200,000 | $10.12M | 3.1% | $21.39 | — | Call | 00973Y108 |
| — | CymaBay Therapeutics Inc | 590,000 | $8.797M | 2.7% | $13.84 | — | EQUITIES | 23257D103 |
| — | Mirati Therapeutics Inc | 200,000 | $8.712M | 2.6% | $40.17 | — | EQUITIES | 60468T105 |
| — | Poseida Therapeutics Inc | 3,567,985 | $8.492M | 2.6% | $3.30 | — | EQUITIES | 73730P108 |
| KRYS | Krystal Biotech Inc | 71,531 | $8.298M | 2.5% | $90.31 | +35.1% | EQUITIES | 501147102 |
| BIIB | Biogen Idec Inc | 28,069 | $7.214M | 2.2% | $290.33 | -7.9% | EQUITIES | 09062X103 |
| URGN | Urogen Pharma Ltd | 508,883 | $7.129M | 2.2% | $16.05 | 0.0% | EQUITIES | M96088105 |
| UTHR | United Therapeutics Corp | 31,424 | $7.098M | 2.2% | $214.96 | +7.1% | EQUITIES | 91307C102 |
| — | Praxis Precision Medicines Inc | 4,117,920 | $7.042M | 2.1% | $1.24 | — | EQUITIES | 74006W108 |
| ORIC | Oric Pharmaceuticals Inc | 1,123,345 | $6.796M | 2.1% | $4.17 | +96.6% | EQUITIES | 68622P109 |
| CRNX | Crinetics Pharmaceuticals Inc | 220,000 | $6.543M | 2.0% | $20.61 | 0.0% | EQUITIES | 22663K107 |
| — | Mirati Therapeutics Inc | 150,000 | $6.534M | 2.0% | $40.17 | — | Call | 60468T105 |
| COGT | Cogent Biosciences Inc | 651,372 | $6.351M | 1.9% | $11.33 | +4.7% | EQUITIES | 19240Q201 |
| — | Mersana Therapeutics Inc | 5,000,000 | $6.35M | 1.9% | $1.86 | — | EQUITIES | 59045L106 |
| RYTM | Rhythm Pharmaceuticals Inc | 260,537 | $5.973M | 1.8% | $20.46 | +9.5% | EQUITIES | 76243J105 |
| MGNX | MacroGenics Inc | 1,264,158 | $5.891M | 1.8% | $5.63 | -11.6% | EQUITIES | 556099109 |
| BCRX | BioCryst Pharmaceuticals Inc | 791,671 | $5.605M | 1.7% | $10.45 | -31.2% | EQUITIES | 09058V103 |
| NVO | Novo Nordisk A/S | 60,000 | $5.456M | 1.7% | $90.94 | — | EQUITIES | 670100205 |
| — | Akero Therapeutics Inc | 106,600 | $5.392M | 1.6% | $21.39 | — | Put | 00973Y108 |
| VCYT | Veracyte Inc | 239,571 | $5.35M | 1.6% | $29.85 | -13.9% | EQUITIES | 92337F107 |
| KALV | KalVista Pharmaceuticals Inc | 530,400 | $5.108M | 1.5% | $7.46 | +36.9% | Call | 483497103 |
| GOSS | Gossamer Bio Inc | 6,130,268 | $5.105M | 1.5% | $1.15 | 0.0% | EQUITIES | 38341P102 |
| OLMA | Olema Pharmaceuticals Inc | 407,801 | $5.036M | 1.5% | $6.21 | +64.0% | EQUITIES | 68062P106 |
| HUM | Humana Inc | 10,000 | $4.865M | 1.5% | $456.59 | 0.0% | EQUITIES | 444859102 |
| VRTX | Vertex Pharmaceuticals Inc | 13,765 | $4.787M | 1.5% | $244.76 | +42.9% | EQUITIES | 92532F100 |
| GILD | Gilead Sciences Inc | 62,789 | $4.705M | 1.4% | $71.30 | -0.9% | EQUITIES | 375558103 |
| PLRX | Pliant Therapeutics Inc | 250,409 | $4.342M | 1.3% | $18.26 | -5.1% | EQUITIES | 729139105 |
| CRBU | Caribou Biosciences Inc | 892,786 | $4.268M | 1.3% | $6.20 | 0.0% | EQUITIES | 142038108 |
| — | ImmunoGen Inc | 250,000 | $3.967M | 1.2% | $17.62 | — | Call | 45253H101 |
| TELA | Tela Bio Inc | 490,471 | $3.924M | 1.2% | $10.18 | -8.7% | EQUITIES | 872381108 |
| INSM | Insmed Inc | 150,387 | $3.797M | 1.2% | $26.84 | -14.8% | EQUITIES | 457669307 |
| MIRM | Mirum Pharmaceuticals Inc | 110,114 | $3.48M | 1.1% | $22.95 | +19.3% | EQUITIES | 604749101 |
| — | CymaBay Therapeutics Inc | 200,000 | $2.982M | 0.9% | $13.84 | — | Call | 23257D103 |
| RVPH | Reviva Pharmaceuticals Holdings Inc | 564,000 | $2.752M | 0.8% | — | — | Put | 76152G100 |
| ZURA | Zura Bio Ltd | 404,040 | $2.667M | 0.8% | $7.22 | -7.4% | EQUITIES | G9TY5A101 |
| TERN | Terns Pharmaceuticals Inc | 500,000 | $2.515M | 0.8% | $6.60 | -3.8% | EQUITIES | 880881107 |
| — | Molecular Templates Inc | 354,608 | $2.241M | 0.7% | $6.32 | — | EQUITIES | 608550208 |
| KALV | KalVista Pharmaceuticals Inc | 228,934 | $2.205M | 0.7% | $7.46 | +36.9% | EQUITIES | 483497103 |
| TRVI | Trevi Therapeutics Inc | 927,415 | $2.022M | 0.6% | $3.10 | -27.2% | EQUITIES | 89532M101 |
| KOD | Kodiak Sciences Inc | 1,114,461 | $2.006M | 0.6% | $3.53 | 0.0% | EQUITIES | 50015M109 |
| CERS | Cerus Corp | 1,203,890 | $1.95M | 0.6% | $5.53 | -62.4% | EQUITIES | 157085101 |
| XENE | Xenon Pharmaceuticals Inc | 53,996 | $1.845M | 0.6% | $29.94 | +24.9% | EQUITIES | 98420N105 |
| — | Evogene Ltd | 3,100,000 | $1.818M | 0.6% | $0.60 | — | EQUITIES | M4119S104 |
| NTLA | Intellia Therapeutics Inc | 53,018 | $1.676M | 0.5% | $53.42 | -27.4% | EQUITIES | 45826J105 |
| — | Akero Therapeutics Inc | 31,336 | $1.585M | 0.5% | $21.39 | — | EQUITIES | 00973Y108 |
| ACRS | Aclaris Therapeutics Inc | 199,000 | $1.363M | 0.4% | $15.96 | -46.4% | Call | 00461U105 |
| — | Aerovate Therapeutics Inc | 100,000 | $1.357M | 0.4% | $13.57 | — | EQUITIES | 008064107 |
| PRTA | Prothena Corporation PLC | 26,629 | $1.285M | 0.4% | $64.50 | -7.9% | EQUITIES | G72800108 |
| ROIV | Roivant Sciences Ltd | 100,000 | $1.168M | 0.4% | $11.31 | 0.0% | EQUITIES | G76279101 |
| ALKS | Alkermes Plc | 41,455 | $1.161M | 0.4% | $30.24 | -3.1% | EQUITIES | G01767105 |
| SRPT | Sarepta Therapeutics Inc | 9,197 | $1.115M | 0.3% | $129.09 | -12.4% | EQUITIES | 803607100 |
| — | Mersana Therapeutics Inc | 801,600 | $1.018M | 0.3% | $1.86 | — | Call | 59045L106 |
| ANNX | Annexon Inc | 399,716 | $943K | 0.3% | $4.34 | -30.3% | EQUITIES | 03589W102 |
| — | 89bio Inc | 60,247 | $930K | 0.3% | $15.23 | — | EQUITIES | 282559103 |
| BMRN | BioMarin Pharmaceutical Inc | 10,000 | $885K | 0.3% | $94.11 | -5.5% | EQUITIES | 09061G101 |
| SGMT | Sagimet Biosciences Inc | 100,000 | $880K | 0.3% | $13.31 | 0.0% | EQUITIES | 786700104 |
| SDGR | Schrodinger Inc | 30,311 | $857K | 0.3% | $25.19 | +60.0% | EQUITIES | 80810D103 |
| VYGR | Voyager Therapeutics Inc | 103,966 | $806K | 0.2% | $11.31 | — | EQUITIES | 92915B106 |
| — | Karyopharm Therapeutics Inc | 561,955 | $753K | 0.2% | $3.70 | — | EQUITIES | 48576U106 |
| VRDN | Viridian Therapeutics Inc | 47,438 | $728K | 0.2% | $29.66 | -35.7% | EQUITIES | 92790C104 |
| — | Point Biopharma Global Inc | 93,700 | $625K | 0.2% | $7.62 | — | EQUITIES | 730541109 |
| RZLT | Rezolute Inc | 433,240 | $572K | 0.2% | $2.06 | -20.8% | EQUITIES | 76200L309 |
| — | Aligos Therapeutics Inc | 631,887 | $472K | 0.1% | $0.87 | — | EQUITIES | 01626L105 |
| CGEN | Compugen Ltd | 350,188 | $326K | 0.1% | $0.89 | +24.3% | EQUITIES | M25722105 |
| CLYM | Eliem Therapeutics Inc | 121,110 | $319K | 0.1% | $4.94 | -44.8% | EQUITIES | 28658R106 |
| RLMD | Relmada Therapeutics Inc | 100,000 | $300K | 0.1% | $2.97 | 0.0% | EQUITIES | 75955J402 |
| SNDX | Syndax Pharmaceuticals Inc | 20,000 | $290K | 0.1% | $20.82 | -9.1% | EQUITIES | 87164F105 |
| ELOX | Eloxx Pharmaceuticals Inc | 54,075 | $260K | 0.1% | $4.22 | +32.8% | EQUITIES | 29014R202 |
| BHVN | Biohaven Ltd | 10,000 | $260K | 0.1% | $17.21 | +20.7% | EQUITIES | G1110E107 |
| — | Clene Inc | 500,000 | $248K | 0.1% | $0.69 | — | EQUITIES | 185634102 |
| — | Acelyrin Inc | 23,000 | $234K | 0.1% | — | — | Put | 00445A100 |
| SRRK | Scholar Rock Holding Corp | 9,711 | $68,948 | 0.0% | $6.72 | 0.0% | EQUITIES | 80706P103 |
| RCKTW | Rocket Pharmaceuticals Inc Wts | 104,828 | $17,821 | 0.0% | $0.11 | — | WARRANTS | 77313F114 |
| ACRS | Aclaris Therapeutics Inc | 2,400 | $16,440 | 0.0% | $15.96 | -46.4% | Put | 00461U105 |